Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Observational Retrospective-prospective Study of Prevalence, Clinical Characteristics of Hereditary Transthyretin Amyloidosis Polyneuropathy in Russian Patients Undergoing Surgery for CTS in Real Clinical Practice

NCT06414746 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT06414746
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06414746 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Observational Retrospective-prospective Study of Prevalence, Clinical Characteristics of Hereditary Transthyretin Amyloidosis Polyneuropathy in Russian Patients Undergoing Surgery for CTS in Real Clinical Practice
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
December 29, 2023
Completion date
June 12, 2025
Enrollment
721 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

amyloidosis, carpal tunnel syndrome, hereditary transthyretin amyloidosis, polyneuropathy